Source: FierceBiotech by John Carroll | Apr 21, 2016 5:02pm Allergan is racking up another new deal in the wake of its broken merger with Pfizer. Thursday evening the company announced a deal to buy Boston-based Topokine Therapeutics for $85 million up front. The buyout gives Allergan a late-stage drug…...